BSE Live
Apr 16, 16:01Prev. Close
107.03
Open Price
107.34
Bid Price (Qty.)
108.45 (2)
Offer Price (Qty.)
112.20 (100)
NSE Live
Apr 17, 09:04Prev. Close
109.91
Open Price
111.00
Bid Price (Qty.)
110.00 (4)
Offer Price (Qty.)
111.00 (50)
| Profit & Loss account of Indo US Bio-Tech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 103.84 | 72.84 | 61.74 | 50.05 | 40.09 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 103.84 | 72.84 | 61.74 | 50.05 | 40.09 | |
| Total Operating Revenues | 103.84 | 72.84 | 61.74 | 50.05 | 40.09 | |
| Other Income | 0.18 | 0.32 | 0.02 | 0.18 | 0.04 | |
| Total Revenue | 104.02 | 73.16 | 61.77 | 50.24 | 40.13 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchase Of Stock-In Trade | 20.55 | 5.88 | 5.27 | 2.18 | 2.46 | |
| Operating And Direct Expenses | 70.96 | 68.96 | 42.97 | 45.20 | 25.11 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -18.85 | -25.47 | -3.12 | -11.21 | -2.32 | |
| Employee Benefit Expenses | 1.09 | 1.17 | 1.52 | 0.71 | 0.52 | |
| Finance Costs | 1.49 | 1.51 | 1.18 | 1.18 | 1.16 | |
| Depreciation And Amortisation Expenses | 1.10 | 0.80 | 0.83 | 0.42 | 0.25 | |
| Other Expenses | 11.15 | 11.50 | 5.73 | 6.26 | 8.81 | |
| Total Expenses | 87.49 | 64.35 | 54.38 | 44.75 | 36.00 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 16.53 | 8.80 | 7.39 | 5.49 | 4.13 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 16.53 | 8.80 | 7.39 | 5.49 | 4.13 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.32 | 0.37 | 0.34 | 0.38 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.04 | -0.07 | -0.17 | -0.16 | -0.33 | |
| Tax For Earlier Years | -0.02 | 0.26 | -0.02 | 0.03 | -0.64 | |
| Total Tax Expenses | 0.26 | 0.55 | 0.15 | 0.25 | -0.97 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 16.27 | 8.25 | 7.24 | 5.24 | 5.10 | |
| Profit/Loss From Continuing Operations | 16.27 | 8.25 | 7.24 | 5.24 | 5.10 | |
| Profit/Loss For The Period | 16.27 | 8.25 | 7.24 | 5.24 | 5.10 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 8.12 | 4.11 | 7.51 | 8.56 | 8.40 | |
| Diluted EPS (Rs.) | 8.12 | 4.11 | 7.51 | 8.56 | 8.40 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.52 | 0.00 | 0.00 | 0.15 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 3.00 | 0.00 | 0.00 | 3.00 | 0.00 |
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
22.01.2026
Indo US Bio-Tec Standalone December 2025 Net Sales at Rs 22.80 crore, down 3.25% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.04.2026
17.04.2026
15.04.2026
PhysicsWallah shares rise 5% as firm clarifies on report of acquisition of test-prep platform
15.04.2026
12.02.2026
Q3 results impact: Avanti Feeds, Apex Frozen shares rally up to 19% to fresh record highs
11.02.2026
Titan shares rise 3% to new 52-week high as Q3 results impress: Check brokerages' target prices
10.02.2026
Titan Q3 Results: Net profit rises 61% to Rs 1,684 crore on high gold prices, revenue up 43%
10.02.2026
BSE shares jump 6% to fresh record high after strong Q3 results: Brokerages raise target prices
23.01.2026
Matrimony Q3 PAT may dip 21.8% YoY to Rs. 7.8 cr: ICICI Securities
23.01.2026
India Mart Q3 PAT seen up 27.5% YoY to Rs. 154.3 cr: ICICI Securities
23.01.2026
Just Dial Q3 PAT seen up 17% YoY to Rs. 153.6 cr: ICICI Securities
23.01.2026
Nykaa Q3 PAT seen up 105.7% YoY to Rs. 53.7 cr: ICICI Securities